Resources

Renewal of Prescription Drug User Fee Act raises issues for government, public groups

published in Pharmaceutical & Medical Device Law Bulletin | January 1, 2002

Other Recent Articles

And the hits just keep on coming: New DOL guidance on cybersecurity
April 14, 2021  | McAfee & Taft ERISALINC
Immediate employer action required as DOL issues guidance, model notices on COBRA subsidy program
April 8, 2021  | McAfee & Taft EmployerLINC Alert
As Oklahoma data privacy legislation hits roadblock, bill’s original co-authors continue to seek hearing
April 2, 2021
Form I-9 COVID flexibility policy extended until May 31, 2021 for remote employers and workplaces
April 2, 2021  | McAfee & Taft EmployerLINC